Target intelligence / Profile preview

RNA, U4 small nuclear 8, pseudogene (RNU4-8P)

Target
RNU4-8P
Molecular classification
Other (Pseudogene, small nuclear RNA pseudogene)
01

Overview

RNU4-8P is a non-coding RNA classified as a pseudogene related to the U4 small nuclear RNA gene family. Unlike functional U4 genes (such as RNU4-2), which code for small nuclear RNA involved in the spliceosome and mRNA processing, RNU4-8P is a non-functional genomic sequence with no proven biological activity. Pseudogenes do not produce functional RNA or protein products and are generally considered to be evolutionary remnants. RNU4-8P is a pseudogene and does not produce a functional small nuclear RNA used in spliceosome assembly, unlike functional U4 genes (notably RNU4-2). There is no evidence RNU4-8P is or could be a therapeutic target (not a receptor, enzyme, transporter, or similar druggable entity). Recent groundbreaking literature and disease associations focus on functional variants of RNU4-2 (not RNU4-8P), where mutations have been shown to cause a high-prevalence monogenic neurodevelopmental syndrome. None of these works refer to RNU4-8P as the disease-causing entity. If you are seeking the splicing snRNA gene implicated in neurodevelopmental disease, the correct target is RNU4-2, not RNU4-8P. In summary, RNU4-8P is not an active molecule or valid therapeutic/diagnostic target. It is a pseudogene for a member of the U4 small nuclear RNA family, with no known function, therapeutic relevance, or disease involvement. If your intention was to identify the functional U4 snRNA implicated in neurodevelopmental disorders, RNU4-2 is the correct gene.

Other names
U4U4/14LOC124900516RNU4P2

Beyond the preview

Go deeper on RNA, U4 small nuclear 8, pseudogene (RNU4-8P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 8, pseudogene (RNU4-8P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call